PDCD1 and diffuse large B-cell lymphoma: A patient with refractory EBV+ DLBCL associated with secondary hemophagocytic syndrome has been successfully treated by a sequential combination regimen of PD-1 blockade and chimeric antigen receptor T-cells [98].